Tag: Carmat
Carmat: financing guaranteed until July
(CercleFinance.com) – Carmat announced last night that it ended 2021 with cash of 39.2 million euros, which gives the artificial heart manufacturer financial visibility until July 2022. In 2021, its…
Carmat widened its losses in 2021 – 02/16/2022 at 08:43
(AOF) – Carmat recorded a net loss of 61.9 million euros in 2021, compared to 37 million in 2020. The medtech was penalized by a non-recurring charge of 8.1 million,…
STOCK EXCHANGE: CARMAT FALLS
Published on 02/01/2022 at 09:10 BOURSE-CARMAT LOSES 24% AFTER ANNOUNCING THAT IMPLANTATIONS OF ITS AESON ARTIFICIAL HEART WILL NOT RESUME UNTIL OCTOBER …
Carmat: -15%, no resumption of locations before October!
Through Jean-Baptiste Andre Published on 02/01/2022 at 09:31, modified 02/01/2022 at 8:25 p.m. Photo credit © Carmat (Boursier.com) — New cold shower for the shareholders of Carmat. The group, which…
New disappointment on Carmat, what to do after the fall
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? To sell ? What course objective? Our experts engage…
Carmat: Carmat will resume implanting its artificial heart in October 2022
(Reuters) – French company Carmat said on Monday it could not resume implanting its Aeson artificial heart until next October. The group had announced on December 2 the suspension of…
Carmat gives itself time to revive its artificial heart
Cardiologist-surgeon Alain Carpentier, specialist in heart transplantation, in October 2008, shows a heart valve that is part of the artificial heart designed to overcome the worldwide shortage of organ donors,…
Carmat: The Stock Exchange heavily sanctions Carmat, which plans to resume implantations in October
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Carmat will resume implanting its artificial heart in October 2022 – 01/31/2022 at 19:57
Jan 31 (Reuters) – French company Carmat ALCAR.PA said on Monday that it could not resume implants of its Aeson artificial heart until next October. The group had announced on…
Carmat will resume implanting its artificial heart in October 2022 – 01/31/2022 at 20:47
CARMAT WILL RESUME THE IMPLEMENTATIONS OF ITS ARTIFICIAL HEART IN OCTOBER 2022 (Reuters) – French company Carmat said on Monday it could not resume implanting its Aeson artificial heart until…
Carmat will resume implanting its artificial heart in October 2022
Carmat will resume implanting its artificial heart in October 2022 | Photo credits: Carmat Jan 31 (Reuters) – French company Carmat said on Monday it could not resume implanting its…
CARMAT announces the holding of a videoconference on January 31 at 6:00 p.m. in order to take stock of its activities – 01/18/2022 at 7:00 p.m.
CARMAT (FR0010907956, ALCAR, PEA-PME eligible), designer and developer of the most advanced total artificial heart in the world, aimed at offering a therapeutic alternative to patients suffering from end-stage biventricular…